Particle News: Latest Bain Capital news

Bristol Myers and Bain Capital Launch $300 Million Immunology Spinout

The new venture starts with five licensed autoimmune assets under dedicated leadership to accelerate treatments for lupus, psoriasis and related diseases.

3 ARTICLES

2mo ago

Seven & i Prepares for U.S. Tariff Impact as Takeover Battle Intensifies

Particle.news

Bain Capital

Investment company

Bristol Myers and Bain Capital Launch $300 Million Immunology Spinout

Seven & i Approves New Board While Weighing $51.5 Billion Couche-Tard Offer

Warner Music and Bain Capital Form $1.2 Billion Catalog Acquisition Venture

Virgin Australia Soars in $685 Million Return to ASX

Ageas Acquires Esure for £1.3 Billion, Strengthening UK Insurance Presence

SelectQuote Secures $350 Million Investment to Drive Healthcare Growth

UK Engineering Firms Chemring and Wood Group Face Foreign Takeover Bids

KKR Secures Majority Stake in Fuji Soft After Bidding War With Bain

Stada Prepares for Potential Multi-Billion Euro IPO

Canada Goose Q1 Revenue Climbs 22.5% as Losses Deepen

Never miss stories about

Bain Capital

Barcelona’s Revamped Estel Building Opens With 65% of Space Leased

Seven & i Announces Major Restructuring to Counter $47 Billion Takeover Bid

Virgin Australia Secures Early Commitments for $685 Million IPO

Mitsubishi Chemical Sells Pharma Unit to Bain Capital for $3.36 Billion

Krafton to Acquire ADK Group for $517 Million in Largest Investment Yet

Seven & i Prepares for U.S. Tariff Impact as Takeover Battle Intensifies

Never miss stories about

Bain Capital